Pettersson G
Acta Physiol Scand Suppl. 1979;470:1-30.
Serotonin (5-HT) in the mammalian gut is mainly stored in enterochromaffin cells (EC). Vagal or splanchnic nerve stimulation respectively increase portal blood levels of 5-HT and decrease 5-HT content in EC, suggesting a neural control of these cells. Previous studies have also suggested that the vagal effect is mediated via vagal adrenergic nerve fibers, since this effect could be blocked by sympathectomy, removal of the superior cervical sympathetic ganglia or by the administration of a beta-adrenoceptor blocking agent, d, 1-propranolol. In the present study the control of the 5-HT content in EC was studied by a cytofluorimetric method in specimens from rat duodenal mucosa after drug incubations and transmural field stimulation (TFS) in vitro: Incubations in a Krebs' solution containing adrenaline (A), noradrenaline (NA) or isoprenaline (IP) (10(-9)--10(-5) M) caused a decrease of the 5-HT content in EC. For NA and A this effect was concentration-dependent. The effect of A was antagonized by d, 1-propranolol but not by d-propranolol, metoprolol, phentolamine or phenoxybenzamine. This indicates that the effects observed were mediated via a true beta-adrenoceptor mechanism. Acetylcholine (ACh), in the presence of eserine, also decreased the 5-HT content in EC, but was less potent than the adrenergic substances. TFS decreased the 5-HT content of EC to about 75% of unstimulated control levels. The presence of tetrodotoxin or d, 1-propranolol in the stimulation bath antagonized the effect of TFS. In specimens from rats pretreated with 6-OH-dopamine, TFS had no effect. Thus, TFS appears to induce a release of 5-HT from EC mainly by activation of adrenergic nerves. The ultrastructural relationship between nerve terminals and EC was studied in the guinea-pig duodenum. Animals were pretreated with 5-OH-dopamine in order to visualize adrenergic nerves. Near the base of most of the EC examined, at least 3 different types of nerve terminals were observed with the appearance of adrenergic, cholinergic and peptidergic terminals. In addition, dendrite-like processes were demonstrated. No true synapse on EC was found, but the minimal distance between the nerve terminals and EC was 150-250 nm, well within the limits of the "autonomic gap", suggesting a functional neural influence on these cells. The importance of the demonstrated beta-adrenergic control of EC was further studied in vivo. Efferent vagal nerve stimulation in the cat caused increased 5-HT levels in the portal plasma to more than twice the normal values after 15 min stimulation. Administration of the beta-adrenoceptor antagonist d, 1-propranolol in various doses did not abolish, but significantly reduced the response, particularly during the final part of the stimulation period. These results not only confirm a beta-adrenoceptor mediated release of 5-HT, but also suggest that other mechanisms are involved in the total response to vagal nerve stimulation.
血清素(5-羟色胺,5-HT)在哺乳动物肠道中主要储存于肠嗜铬细胞(EC)。迷走神经或内脏神经刺激分别会提高门静脉血中5-HT的水平,并降低EC中的5-HT含量,这表明这些细胞受神经控制。先前的研究还表明,迷走神经效应是通过迷走肾上腺素能神经纤维介导的,因为这种效应可被交感神经切除术、切除颈上交感神经节或给予β-肾上腺素能受体阻断剂d,1-普萘洛尔所阻断。在本研究中,采用细胞荧光测定法,在体外药物孵育和透壁场刺激(TFS)后,对大鼠十二指肠黏膜标本中EC的5-HT含量调控进行了研究:在含有肾上腺素(A)、去甲肾上腺素(NA)或异丙肾上腺素(IP)(10⁻⁹ - 10⁻⁵ M)的 Krebs 溶液中孵育会导致 EC 中 5-HT 含量降低。对于 NA 和 A,这种效应呈浓度依赖性。A 的效应可被 d,1-普萘洛尔拮抗,但不能被 d-普萘洛尔、美托洛尔、酚妥拉明或酚苄明拮抗。这表明观察到的效应是通过真正的β-肾上腺素能受体机制介导的。在存在毒扁豆碱的情况下,乙酰胆碱(ACh)也会降低 EC 中的 5-HT 含量,但效力低于肾上腺素能物质。TFS 使 EC 的 5-HT 含量降至未刺激对照水平的约 75%。刺激浴中存在河豚毒素或 d,1-普萘洛尔可拮抗 TFS 的效应。在用 6-羟基多巴胺预处理的大鼠标本中,TFS 无作用。因此,TFS 似乎主要通过激活肾上腺素能神经诱导 EC 释放 5-HT。在豚鼠十二指肠中研究了神经末梢与 EC 之间的超微结构关系。动物用 5-羟基多巴胺预处理以可视化肾上腺素能神经。在大多数被检查的 EC 基部附近,观察到至少 3 种不同类型的神经末梢,呈现出肾上腺素能、胆碱能和肽能末梢的外观。此外,还证实了有树突样突起。未发现与 EC 的真正突触,但神经末梢与 EC 之间的最小距离为 150 - 250 nm,完全在“自主间隙”范围内,提示对这些细胞有功能性神经影响。在体内进一步研究了所证实的对 EC 的β-肾上腺素能控制的重要性。猫的传出迷走神经刺激在刺激 15 分钟后使门静脉血浆中的 5-HT 水平升高至正常值的两倍以上。给予不同剂量 的β-肾上腺素能拮抗剂 d,1-普萘洛尔并不能消除,但显著降低了反应,特别是在刺激期的最后阶段。这些结果不仅证实了β-肾上腺素能受体介导的 5-HT 释放,还表明在对迷走神经刺激的总体反应中涉及其他机制。